
Heiko Lickert
@lickertheiko
Developmental and stem cell biologist, Professor for Beta Cell Biology @ TUM, Director of Institute for Diabetes and Regeneration @HelmholtzMunich Munich
ID: 1066092437762973696
http://www.helmholtz-muenchen.de/IDR 23-11-2018 22:13:38
2,2K Tweet
3,3K Followers
879 Following



Top altmetrics score 2024: #17šāØ Heiko Lickert (Helmholtz Munich | @HelmholtzMunich) and co-authors show that #inceptor (insulin inhibitory receptor) regulates #insulin stores by directing proinsulin and insulin towards lysosomal degradation. nature.com/articles/s4225ā¦


Nice to see our recent paper from a few weeks back taking off! Thanks and preXmas present to Johanna Siehler and SƔra BilekovƔ and our great team and cooperators Scheltema lab @[email protected] Stephan Speier Ansarullah and others not on X and bluesky.


My top highlight for 2025 - EMBO workshop in Saint Feliu - three exciting days of science crossing boundaries of liver & pancreas research! Co-organised by InĆŖs Cebola Jorge Ferrer ludovic vallier Heiko Lickert & Emma Anderson #livertwitter #islets #masld #diabetes

RESEARCH | Johanna Siehler,SĆ”ra BilekovĆ”, Heiko Lickert et al. (Helmholtz Munich | @HelmholtzMunich): Inceptor (insulin inhibitory receptor) regulates #insulin stores by directing proinsulin and insulin towards lysosomal degradation. nature.com/articles/s4225ā¦

This collaborative project between Helmholtz Munich | @HelmholtzMunich, TU München, & Universität München was led by Leonardo Matta, Peter Weber, & Suheda Erener - Big THX to Maria Rohm, Heiko Lickert et al. & the reviewers & editors Cell Reports



Exciting new tool to make the most out of multimodal single-cell data from our friends and long-term collaborators of the Fabian Theis lab - check it out, it works beautifully and really makes sense out of your complex data! ššš




In her compelling op-ed published Chicago Sun-Times, Society for Developmental Biology President Dr. Carole LaBonne warns that rapid innovation may not be suitable for scienceāwhere careful methodology, peer review, and sustained funding are key. If rushed, it risks breaking the very foundation of scientific



doi.org/10.1016/j.cell⦠ENVLPE, our system for VLP-based delivery of gene editors, is now published in Cell. We showed efficient delivery of base- and prime-editors in primary T cells & in vivo retinal models. Congrats co-first-authors Julian Geilenkeuser & Niklas Armbrust!

